LABORATORY NEWS
-
Pangea Laboratory And Gene Solutions Establish Strategic Collaboration To Advance Cancer Diagnostics In The United States
Pangea Laboratory, a CLIA-certified, CAP-accredited leader in Next-Generation Sequencing (NGS) and molecular diagnostic validation and innovation, today announced a strategic collaboration with Gene Solutions, a global biotechnology company, to validate AI-driven liquid biopsy assays for use in cancer detection, characterization, and monitoring within CLIA/CAP laboratory settings in the U.S. market.
- Zepto Life Technology Launches Plasma-Based FungiFlex® Mold Panel As CLIA Reference Laboratory Test
- Sysmex America Expands CN-Series With CN-9000 To Help Labs Of All Sizes Optimize Workflow
- Cepheid Receives FDA Clearance For Xpert® GI Panel To Support Broad Detection Of Gastrointestinal Pathogens
- Cytespace Africa Labs Expands Molecular Testing Capacity To Advance Clinical Trials Across Sub-Saharan Africa
ARCHIVED NEWSLETTER
- 01.20.26 -- Rats Behind The Wheel: The Right Preclinical Way To Investigate Drug Effects On Driving?
- 01.06.26 -- To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
- 12.23.25 -- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
- 12.09.25 -- What You Should Know About USP's Bioassay Updates
- 11.25.25 -- Lunit & Labcorp To Advance AI-Powered Digital Pathology Research